Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Twice Weekly Steroids and Exercise as Therapy for DMD
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Status
- SUSPENDED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone
- Status
- WITHDRAWN
- Phase
- PHASE1
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
- Status
- RECRUITING
- Phase
- PHASE2
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
- Status
- RECRUITING
- Phase
- PHASE2
Novel Form of Acquired Long QT Syndrome
- Status
- UNKNOWN
- Phase
- PHASE4
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SHR0302 and Steroid As First Line Therapy for Chronic GVHD
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1